These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9132444)

  • 1. [Heart failure and circulatory control peptides].
    Takeshita A
    Nihon Naika Gakkai Zasshi; 1994 Jan; 83(1):138-42. PubMed ID: 9132444
    [No Abstract]   [Full Text] [Related]  

  • 2. Sodium retention in heart failure.
    Cannon PJ
    Cardiol Clin; 1989 Feb; 7(1):49-62. PubMed ID: 2523241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of prostaglandins and angiotensin II in the modulation of renal function in congestive heart failure.
    Packer M
    Circulation; 1988 Jun; 77(6 Pt 2):I64-73. PubMed ID: 2967129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Receptors for vasoactive peptides in experimental hypertension and cardiac insufficiency].
    Schiffrin EL; St-Louis J
    Union Med Can; 1988 Feb; 117(1):133-6. PubMed ID: 2836981
    [No Abstract]   [Full Text] [Related]  

  • 5. Natriuretic peptides: biochemistry, physiology, and therapeutic role in heart failure.
    Stoupakis G; Klapholz M
    Heart Dis; 2003; 5(3):215-23. PubMed ID: 12783635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Atrial natriuretic factor in cardiovascular diseases].
    Nakamura M; Arakawa N; Hiramori K
    Kokyu To Junkan; 1991 Oct; 39(10):971-8. PubMed ID: 1836068
    [No Abstract]   [Full Text] [Related]  

  • 7. Hormones and hemodynamics in heart failure.
    Schrier RW; Abraham WT
    N Engl J Med; 1999 Aug; 341(8):577-85. PubMed ID: 10451464
    [No Abstract]   [Full Text] [Related]  

  • 8. Systemic and renal effects of atrial natriuretic peptide in patients with heart failure treated with angiotensin-converting enzyme inhibitor or in acute saline solution loading.
    Tomiyama H; Watanabe G; Abe M; Okazaki R; Yoshida H; Doba N
    Am Heart J; 2001 Mar; 141(3):422-7. PubMed ID: 11231440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuro-hormonal mechanisms in heart insufficiency--from physiopathology to treatment].
    Cerqueira-Gomes M; Polónia J; Brandão F; Ramalhão C; de Faria DB
    Rev Port Cardiol; 1989 Feb; 8(2):129-48. PubMed ID: 2576635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurohormonal activation and the response to converting enzyme inhibitors in congestive heart failure.
    Kubo SH
    Circulation; 1990 Feb; 81(2 Suppl):III107-14. PubMed ID: 2137052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vasopeptidase inhibition: a new pharmacological principle in the treatment of hypertension and cardiac insufficiency].
    Kolloch R; Offers E
    Dtsch Med Wochenschr; 2001 Nov; 126(47):1342-7. PubMed ID: 11719860
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pathophysiology of congestive heart failure].
    Luzza F; Bruni F; Rizzo F; Carerj S
    Minerva Cardioangiol; 2002 Jun; 50(3):209-19. PubMed ID: 12107401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Growth stimulating properties of angiotensin II on the heart: consequences for therapy of heart failure].
    Schunkert H; Holmer SR; Riegger G
    Z Kardiol; 1993; 82 Suppl 4():1-6. PubMed ID: 8147057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atrial natriuretic peptide as angiotensin II antagonist. A new therapeutic principle?].
    Pfaffendorf M
    Med Monatsschr Pharm; 1992 Jun; 15(6):169-77. PubMed ID: 1535414
    [No Abstract]   [Full Text] [Related]  

  • 15. [Neuro-hormonal mechanisms in heart failure -- from physiopathology to treatment].
    Cerqueira-Gomes M; Polónia J; Brandão F; Ramalhão C; da Faria DB
    Rev Port Cardiol; 2001 May; 20 Suppl 5():V-99-122; discussion V-123-5. PubMed ID: 11515306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
    Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
    Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blockade of the renin-angiotensin system. ACE inhibitors, angiotensin II antagonists or both?].
    Karlsen FM; Kamper AL
    Ugeskr Laeger; 2003 Oct; 165(42):4006-9. PubMed ID: 14610833
    [No Abstract]   [Full Text] [Related]  

  • 18. [Natriuretic peptides and cardiomyopathy].
    Nishigaki K; Fujiwara H
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():95-100. PubMed ID: 15506346
    [No Abstract]   [Full Text] [Related]  

  • 19. [Natriuretic peptides in patients with ischemic heart disease].
    Yoshimura M; Ogawa H
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():88-92. PubMed ID: 15506344
    [No Abstract]   [Full Text] [Related]  

  • 20. Converting enzyme inhibitors and renal function in cardiac failure.
    Robertson JI; Richards AM
    Kidney Int Suppl; 1987 May; 20():S216-9. PubMed ID: 3037172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.